Individuals were then identified as having NMOSD if they tested positive for anti-aquaporin-4 (AQP4) antibodies or displayed one of the key clinical symptoms (including optic neuritis (ON), myelitis, and brain disorders)3. Here, AQP4 is linked to myelitis.